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There is powerful evidence suggesting that etiology 
and pathogenesis of systemic lupus erythematosus has 
both genetic and environmental components. U nfor­
tunately, understanding the genetics of lupus has been 
impeded by knowing the pattern of inheritance. In­
deed, a complex mode of inheritance for the lupus dis­
ease phenotype is suggested by the known characteris­
tics of this disorder. Twenty-five multiplex pedigrees 
for lupus have been enrolled and have been used to 
evaluate power to reveal linkage. The power to find 
linkage in these pedigrees is greater for autosomal re­
cessive than for autosomal dominant modes of inheri­
tance. Once 100 similar pedigrees are available for 
AUTOIMMUNITY AND ENVIRONMENT 
The idiopathic rheumatic diseases have mystified generations of 
gifted clinicians and investigators. Perhaps none of these disorders 
has consumed as much attention as systemic lupus erythematosus, 
the classic prototype of a systemic autoimmune disease. Indeed, the 
ubiquitous presence of autoantibodies in these patients is the only 
feature leading the community of investigators toward the consen­
sus that an autoimmune basis for the etiology and pathogenesis of 
this disorder is likely. 
Many features of systemic lupus erythematosus suggest that the 
environment is an important component in pathogenesis. Disease 
may first become clinically apparent at any age of life, in children as 
well as in the elderly, though the second through the fifth decade 
are the most ordinary ages of onset. Affected family members tend 
to have onset more closely in time than in age [1]. In some studies 
pets living with affected individuals also tend to have evidence for 
autoimmunity [2]. Disease clustering, however, has not been re­
ported. Even diet is relevant. L-canavanine, which is an analog of 
arginine and found in alfalfa induces systemic lupus erythematosus 
in primates [3,4]. The use of a variety of medications is associated 
with autoimmunity and, less commonly, with "drug-induced 
lupus," which shares some features found in systemic lupus ery­
thematosus. A relationship to a variety of viruses has been suspected, 
but none of them have clearly been established as etiologically rele­
vant in lupus. 
FAMILIAL CONCORDANCE OF LUPUS 
On the other hand, there is also powerful, but very incomplete, data 
supporting heritable components in the development of lupus. The 
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analysis our results predict that linkage is likely to be 
present for genetic models with relatively relaxed re­
quirements. At loci operating by autosomal recessive 
inheritance linkage should be detectable despite ge­
netic homogeneity as low as 40% and penetrance as low 
as 50%. For loci operating by autosomal dominant in­
heritance genetic homogeneity must be 60% or more 
when penetrance is as low as 50% to be able to establish 
linkage. Available preliminary data are also consistent 
with a possible genetic linkage of FcgammaRIIIpMN with 
lupus in American Black pedigrees multiplex for 
lupus.] Invest Dermatoi10J:144S-149S, 1994 
most compelling evidence for a genetic component in the origin of 
lupus is the variation of concordance with degree of relationship. 
When one member of a monozygotic twin pair has lupus the second 
has a 24% to 69% likelihood of also having lupus [5-8]. Mean­
while. the dizygotic and sibling concordance rate is identical and 
ranges between 2% and 5%, which remains more than an order of 
magnitude higher than the prevalence in the general population. 
This observation strongly supports a genetic component in the ex­
pression of lupus. 
There is additional information in the concordance data. Neil 
Risch has shown that reduction of concordance by more than a 
factor of two with each degree of relationship is consistent with 
multiplicative (or epistatic) models of inheritance in presumed 
complex disorders [9]. In lupus the ratio of concordance between 
the zero order of genetic variation (monozygotic twins) and the first 
order of genetic relationship (dizygotic twins and siblings) is be­
tween five and 30. 
Not surprisingly. the suspicion that lupus has a genetic compo­
nent is confounded by the absence of an explicit model that accounts 
for the pattern of inheritance observed in families. As such, the 
mechanism of inheritance that explains the distribution of the lupus 
disease phenotype in families is not known. 
GE.NE.TICS OF LUPUS IN ANIMALS 
Animal models of lupus also provide proof that a genetic origin of 
lupus is possible in mammals. The murine MRL /pr /Ipr�train devel­
,ops lymphoproliferation and autoimmunity. Its propensity for 
lupus has been linked to the Fas gene on chromosome 19 of the 
mouse [10]. Other genes also contribute to autoimmunity in MRL 
Ipr/lpr mice. 
The mutation responsible for the genetic effect has been fully 
characterized. Fas produces a molecule that is important in mediat-
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ing apoptosis ofT cells [10]. The genetic basis for the well-known 
murine NZB /NZW model is complex and may involve at least 
four genes [11]. The histocompatibility genes appear to make an 
important contribution toward the Fl into parent model of murine 
lupus [12]. There are other models of lupus in animals that suggest a 
genetic component [11]. Indeed, lupus-like autoimmunity in dogs 
has defied segregation analysis, which means that no known mode 
of inheritance suffices as an explanation to relate the observed phe­
notype to a postulated genotype and mechanism of inheritance [13]. 
AUTOIMMUNITY TRAIT IN LUPUS 
The most serious effort to define the genes involved in lupus hts ' 
been made by Wilma Bias and her colleagues in Baltimore [14 - 17]. 
In a series of elegant studies they have shown that finding "autoim­
munity" in the families of patients with autoimmune disorders, 
including lupus, may have a simpler mode of inheritance than does 
lupus or other immune-mediated disease phenotypes. The autoim­
mune phenotype studied was defined as a positive antinuclear anti­
body, biologic false-positive VDRL, anti-single-stranded DNA, or 
any immune-mediated disorder. Their optimal model estimates a 
population prevalence of 0.1 for an "autoimmunity" gene with a 
penetrance of 92% in female and 49% in male subjects [17]. They 
were able to eliminate linkage of "autoimmunity" to the histocom­
patibility genes under this model. Although the model does not 
strictly pertain to the lupus phenotype, the gene postulated to exist 
could easily be one of a number of loci interacting by epistasis that 
are important in genetics of lupus. 
That a genotypic model of autoimmunity is related to the genet­
ics of lupus is suspected from the high frequency and variety of 
autoantibodies found in these pedigrees. Antinuclear antibodies, 
anti-thyroglobulin antibodies, rheumatoid factor, and anti-Ro anti­
bodies are commonly found [14-18]. Indeed, there is some evi­
dence that the twin concordance for particular autoantibody speci­
ficities may be substantially greater than the concordance for the 
lupus disease phenotype [19]. 
GENETIC ASSOCIATION WITH LUPUS 
The likelihood of finding systemic lupus erythematosus is also in­
creased by other genetic features. Sex is very important. At least two 
thirds of lupus patients are women. Sex chromosomes may be even 
more important because Kleinfelter's patients (XXY) may have an 
increased incidence of lupus. In the United States blacks are three­
fold more likely to develop lupus than are whites. Perhaps this racial 
difference also has a genetic explanation. 
Some complement component deficiency states predispose to 
lupus. Indeed, lupus has been described with deficiencies of each of 
the complement components, but the greatest risk is conferred by 
the absence of the early components of the classical pathway of 
complement activation: Clq, Clr, Cis, C2, and C4 [20]. Heterozy­
gous deficiency of a C4A gene has been related to an increased risk 
of developing lupus in many of the cohorts evaluated. The conclu­
sion that this is an important allele at a locus that contributes to the 
risk of having the phenotype must be tempered by the realization 
that the C4A locus is in the major histocompatibility complex 
where effects of linkage disequilibrium may play a major role. In­
deed, HLA-DR3, which confers ip.crease of disease in many studies, 
is in linkage disequilibrium with C4A *Q, a null allele of C4A. 
Moreover, a large cooperative European study has failed to find an 
association between C4A*QO and lupus [21] . 
Of course, it is well known that HLA-DR3 is associated with 
lupus in Northern European populations [22]. Many other HLA 
associations have been described in other populations and at this 
point it is difficult to know what these associations are teaching us 
about the disease. Again, linkage disequilibrium poses an important 
consideration that prevents a clear interpretation. 
Two patients have been described with deficiencies of Fc�­
RIIIpMN that result in a partial or complete loss of expression of this 
IgG receptor [23,24]. The gene codes for the low-affinity receptor 
of IgG on polymorphonuclear leukocytes. There has apparently 
been a gene duplication here because the neighboring locus has a 
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Figure 1. Model for lupus pathogenesis. The environmental stimulus 
leads to tissue infection or injury. Eventually lupus autoantigens become 
involved in an immune response that is dependent upon histocompatibility 
alleles and T-cell receptors. Both of these cell-surface molecules are highly 
polymorphic. The autoantibodies generated and their consequences can be 
modulated by Fe receptors and complement components. Each of the mole­
cules with a suspected pathogenic or etiologic role is indicated by 
**?genes?**. 
very similar sequence and codes for the low-affinity IgG receptor 
found on natural killer cells and macrophages. Interestingly, 
Fcgam .... RIIIpMN is anchored to the membrane by a glycosyl-phos­
phatidylinositol linkage, whereas the amino acid polypeptide chain 
of Fc RIIIpMN spans the cell membrane. Presumably, the form 
foun;r&e"e in plasma [25] is derived from polymorphonuclear leu­
kocytes. of course, IgG receptor function has the capacity to influ­
ence antigen processing as well as the disposition of immune com­
plexes, either of which may profoundly affect the potential of an 
individual to develop lupus. 
One of these FcgammaRIIIpMN-deficient patients had what appears 
to be a complete absence of this IgG receptor [23], whereas the 
second patient described had a partial deficiency [24]. Because they 
were an American black and a presumed European (though the 
ethnic and racial origin of the latter was not explicitly identified) 
and because the defects are different in the two, the mutations in­
volved appear to have had different evolutionary origins. 
GENETIC ASSOCIATION WITH AUTOANTIBODIES 
There are also genetic effects that operate at the level of serologic 
autoimmunity in lupus. Our emphasis in this report is upon the 
effects observed at the level of the genetic components important 
for developing lupus. Bear in mind, however, that autoantibodies 
have been related to immunogenetic alleles in lupus patients. For 
example, anti-Ro is related to the DQ1/DQ2 heterozygous state 
and to the presence of a restriction fragment length polymorphism 
of the T -cell- receptor beta chain [26,27]. Anti-La appears to be best 
related to the HLA-B8, C4A*QO,DR3 haplotype and anti-nRNP 
to DR4 or DQ3 [28,29]. Anti-phospholipid antibody has been asso­
ciated with HLA-DQw7 [30]. 
A MODEL OF DISEASE PATHOGENESIS 
The realization that autoantibodies are more powerfully associated 
with clinical manifestations than are immunogenetic features has 
led to an explanation for the variability of the disease [28]. Under 
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Figure 2. Separation of the D1SH7 alleles in a pedigree with three 
sisters affected with systemic lupus erythematosus. Alleles are identi­
fied by migration in agarose. From left to right the alleles of the father, 
mother, and four daughters are presented. The three affected daughters are 
identified by closed circles. 
the proposed model (Fig 1) the risks of disease, of particular auto­
antibodies and of individual clinical manifestations of disease are the 
result of at least partially separable genetic influences. Once poten­
tiated for the lupus phenotype the particular immunogenetics of the 
affected individual play the greatest role in determining the autoan­
tibody specificities found. In turn and in combination, these deter­
mine many of the clinical manifestations observed in lupus patients . 
Hence, the associations of anti-Ro, for example, with photosensi­
tivity, nephritis (when anti-La is not also present) , pneumonitis, 
congenital heart block, and neonatal lupus dermatitis are compre­
hensible within the context of a highly variable clinical disorder. 
GENETIC ANALYSIS OF LUPUS 
The ongoing revolution in applied genetics has fundamentally 
changed the prospect for discovering the genes that lead to lupus . 
Tools only recently available will make genetics of complex diseases 
accessible for the first time. There is a progressively more detailed 
map of the human genome. The constantly enlarging database of 
human sequences provide an increasingly useful resource for de­
scribing the differences between alleles at the nucleic acid sequence 
level. In addition, advances in the mathematical theory, software 
design, and computing capacity have contributed toward making 
the difficult complex genetic disease problems soluble. 
Large numbers of highly polymorphic co-dominant DNA mi­
crosatellite markers also have the profoundly important advantage 
of revealing genotype without the traditional impediment of begin­
ning with a phenotype at the level of the marker locus. The collec­
tion of genetic data is enormously simplified by the application of a 
single, straightforward technology to establish which alleles are 
present. Indeed, single-stranded DNA primers and the polymerase 
chain reaction make allele assignments on the basis of the size of the 
expanded DNA fragment. The DNA microsatellite alleles vary 
from one another by the number of dinucleotide, trinucleotide or 
tetranucleotide sequence repeats present and are easily distinguish­
able by electrophoresis . 
An example of the microsatellite alleles at D 1 S 117 in a pedigree 
that contains three sisters with lupus is presented in Fig 2. All three 
affected sisters inherit the same pair of alleles from their parents. 
This pedigree makes an impressive contribution to the maximum 
likelihood for linkage (lod = 1.29). The sib-pair approach also 
shows how unexpected this finding is (chi square = 6.0, P < 
0.007). 
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LINKAGE PRECEDING SEGREGATION: 
ANALYTIC ALTERNATIVES 
Describing the nucleic acid differences in the alleles that are respon­
sible for the disease phenotype (or other effect being studied) and 
subsequently explaining how these alleles cause the phenotype are 
the major goals of most modern genetic studies. For most disorders, 
however, the loci involved have not been identified. The only sys­
temic approach to find them now available is to locate the genetic 
effects in the genome by linkage analysis. 
Traditionally, one would only approach a linkage study in the 
presence of a genetic model for the inheritance of the phenotype. 
Such a segregation analysis describes how the underlying genotype 
is likely to result in the observed phenotype. The absence of a model 
for genetic segregation surrenders information that could otherwise 
be exploited for finding linkage. 
Of the analytical methods available, the maximum likelihood 
method (or lod score method) has greatest capacity to establish 
linkage. Its application requires that the model be specified. In con­
trast, the sib-pair method along with its many modifications is less 
statistically powerful, but does not require that the mode of inheri­
tance be known or assumed. Here the observed tendency of marker 
alleles to be inherited together at the loci being evaluated, and 
thereby reveal linkage, is compared to the random assortment of 
alleles among affecteds in the absence of linkage. Actually, Penrose 
used this method in 1935 to establish the first known example of 
linkage in humans , that blood type in linked to red hair [31]. 
The increased power derived from the new advances has allowed 
important changes in the paradigm of genetic analysis. No longer is 
it first required for a segregation analysis to establish the genetic 
model. Linkage provides access to establishing the mode of inheri­
tance as well as to identifying the particular genes involved [32]. 
There are very good reasons to suspect a genetic origin for lupus, 
as discussed above. This disorder is likely to have a complex (or, 
even worse, to have a number of complex) genetic mechanism(s) 
responsible for the phenotype. Before embarking upon a study to 
address solving the complex genetic origins of lupus it is important 
to estimate how much work is likely to be required. In genetically 
complex diseases for which virtually nothing is known, the analysis 
is, by necessity, restricted to multiplex pedigrees. As an exception to 
this rule a recent analytical advance provides a test which in the 
presence of linkage disequilibrium reveals linkage in monoplex 
pedigrees [33]. This approach, however, is limited to regions of the 
genome where genetic associations are already known and where 
linkage disequilibrium exists. 
POWER ANALYSIS BY SIMULATION 
Under these circumstances, it is important to estimate how many 
mutiplex pedigrees diseases must be collected to expect a successful 
effort to establish linkage. Simulation experiments are able to di­
rectly address this question. We first consider theoretical pedigrees 
and then we evaluate actual edigrees that are multiplex for lupus 
and that have been collecte in preparation for a linkage study of 
lupus . 
SIMULATION WITH THEORETICAL PEDIGREES 
If wei assume that major genetic effects operate by an autosomal 
m0de 'of inheritance, then we only need to explore the consequences 
of recessive and of dominant genotypic mechanisms for phenotype 
expression. Other assumptions and constraints are necessary to sim­
ulate the capacity of this approach to establish linkage. If we restrict 
pedigree structure to two affected siblings under circumstances in 
which both parents are available (Fig 3), then the simplest pedigree 
with the least powerful relationship informative for linkage can be 
evaluated. Because the microsatellites chosen for analysis are highly 
polymorphic we will assume for now that both parents are hetero­
zygotes. (How less informative allele assortment influences the re­
sults will be discussed subsequently). 
The contribution to the lod score using the maximum likelihood 
method by each pedigree can be estimated. If the parameters of the 
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Pigure 3. Simulation experiments in theoretical pedigrees. A pre­
sents the pedigree composed of a heterozygous father with alleles 1 and 2 at 
the marker locus, a heterozygous mother with alleles 3 and 4, and two 
affected offspring who each have some combination of 1 or 2 and 3 or 4. 
B presents the average 100 score each pedigree would contribute if an autoso­
mal recessive mode of inheritance is operative. The influence of lowered 
homogeneity and increased recombination fraction is also presented. 
C presents the power for detecting a dominant mode of inheritance with 
models of inheritance as functions of homogeneity and recombination frac­
tion. Homo(%) indicates the level of genetic homogeneity in the models 
being evaluated. For each point presented in B and C 4000 pedigrees were 
generated and analyzed with the SUNK program of the UNKAGE package 
of genetic linkage programs [34]. 
underlying genotype are assumed, we can then measure the devia­
tion from the situation in which lupus is not linked at the locus 
being evaluated. We have generated 4000 replicates of these simple 
pedigrees and analyzed the results (Fig 3). The SLINK computer 
program that has been applied here is part of the LINKAGE soft­
ware system and is available for this and similar problems [34]. 
For example, if there is linkage with no recombination (theta = 
0) at the locus being evaluated and if all pedigrees are linked with 
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lupus at this locus (homogeneity = 100%), then an average contri­
bution toward the lod score may be determined by analyzing many 
pedigrees. Recessive models show more deviation from the un­
linked result, so they make about a tenfold-higher average contri­
bution toward finding linkage (lod = 0.5 for each model pedigree 
evaluated) than if the disease phenotype is expressed via an autoso­
mal dominant mode of inheritance (lod = 0.05) (Fig 3B.C). 
Each point presented in Fig 3B,C represents a different set of 
assumptions and a separate 4000 simulated pedigrees. Models have 
been tested for a variety of recombination fractions (0.00 to 0.20) 
and levels of homogeneity (20% to 1000/0). The surface thereby 
generated tells us what the contribution toward the lod score is 
when only affected offspring are considered and when both parents 
are always available. 
Our estimates are that it is feasible to collect and analyze about 
100 pedigrees. If so, and if they have the structure and heterogeneity 
assumed above, then the linkage (lod > 5) of genes that operate by a 
recessive mode of inheritance will be discoverable even though the 
recombination fraction is higher or the homogeneity is lower (Fig 
3B). In contrast,linkage for genes with dominant models of inheri­
tance will be more difficult to establish in only 100 such Jledigrees 
(Fig 3C). At 100% homogeneity and a recombination of 0.05 an 
average fod of only 0.04 is obtained. This means that 120 pedigrees 
would have 500/0 power to detect linkage when lod > 5 is required. 
The simulations presented in Fig 3 evaluate the situation when 
both parents are doubly heterozygous and share no alleles at the 
locus being evaluated. When parents are double heterozygotes, but 
share one allele, the average lod score from each pedigree is un­
changed. If they are double heterozygotes sharing both alleles, then 
each such pedigree has an average of 87% of power to establish 
linkage found when the (larents are doubly heterozygous with dif­
ferent alleles (as in Fig 3). 
If one parent is a heterozygote and the other a homozygote at the 
marker locus then there is only about 16% of the capacity to define 
linkage compared to the doubly and differently heterozygous theo­
retical pedigrees. These considerations with less informative pedi­
grees will have only a minor effect upon our power analysis because 
the heterogeneity of the selected microsatellites is so high. 
SIMULATION WITH REAL PEDIGREES 
Fortunately, the actual pedigrees provide a somewhat more promis­
ing picture for detecting linkage than found in the theoretical pedi­
grees presented above. Indeed, at this point DNA and clinical infor­
mation is available from members of 25 pedigrees, each of whom is 
multiplex for lupus. The real pedigrees include unaffected members 
and so allowance for penetrance of less than 100% is important. 
They also include relationships among affecteds beyond only sib­
lings and are much more complex than the theoretical pedigrees 
(Table I). 
The structures of the real pedigrees are not consistent with a 
dominant mode of inheritance with 100% penetrance anc:l, there­
fore, this model cannot be simulated. This is because we have only 
considered simple mechanisms of autosomal inheritance in this 
treatment. Epistasis is too complicated to be simulated. So it is possi­
ble that a dominant gene operates in lupus with complete pene­
trance, but learning this will require a fully established genetic 
model, including the identification of the major contributing loci 
The results show that linkage of dominant genes remains more 
difficult to detect (Fig 4). The least genetically informative model 
simulated is for dominant inheritance with penetrance at 50%, re­
combination at 0.05, homogeneity at 40%. Even here an average lod 
score of 0.8 will be obtained in our 25 pedigrees. A cohort of 100 
similar pedigrees is predicted to produce a 100 score of 3.2, which 
would lead an investigator to become very suspicious that the locus 
was weakly linked. 
If the twin concordance can be used as a guide, then the models 
with 500/0 penettance are probably the best to consider (Fig 4A,C). 
We have also simulated the model of autoimmunity proposed by 
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Table I. Properties of 2S Actual Pedigrees that Are 
Multiplex for Lupus 
Number 
Pedigrees 25 
Individuals 448 
Average membership 18.8 
Male 203 (45%) 
Affected 4 (5%) 
Unaffected 199 (54%) 
Female 245 (55%) 
Affected 74 (95%) 
Unaffected 171 (460/0) 
Pedigrees' 
Duplex 11 
Triplex 9 
Tetraplex 4 
Hexaplex 1 
Affected pairingsb 
Sibs 36 
Parents 13 
Cousin 10 
Aunt 10 
Grandchild 1 
>Cousin 10 
• The number of pedigrees with two, three, four, and six living affected subjects is 
presented. 
� All pairs of living affected relatives found in 25 pedigrees are presented, where sibs 
indicates a sibling pair; parent, a parent-progeny pair; cousin, two first cousins; aunt, an 
affected-aunt pair; grandchild, affected-grandchild pair; >cousin, a pair more distant 
than nrst cousins. 
Bias for lupus and for antinuclear antibodies in these pedigrees. 
There is sufficient power to find linkage if this model is operating in 
either lupus or for the presence of antinuclear antibodies (Fig 4D.E. 
respectively). 
GENETIC EFFECT AT D1S117 
Finally, we have taken a candidate gene approach to this problem. 
Our top candidate gene is Fc,ammaRIIIpMN' which is found on chro­mosome 1 at q23. D1S117 IS the closest marker locus to FCgaDlD!a­
RIIIpMN that is available to us at this time. Analysis in the 14 pedi­
grees analyzed to date shows a weak effect in the optimal model 
with a lod score of 1.2 at a recombination frequency of 0, a pene­
trance of 100%, and a homogeneity of 40%, assuming recessive 
inheritance. When these results are analyzed by race, however, 
almost the entire effect is present in the four black families where 
the optimal lod score is 2.38 at a penetrance of 88% with 100% 
genetic homogeneity. Certainly, the genetic differences between 
blacks and whites could be an obvious basis for the racial difference 
in disease prevalence. 
PROSPECT FOR A GENETIC UNDERSTANDING 
The new experimental technology and accompanying development 
of an increasingly detailed understanding of the human genome . 
have revolutionized our capacity to discover genetic origins of dis­
ease. For problems like the genetics of lupus, they make the previ­
ously impossible now only very difficult. In any case, this should be 
the decade during which the genetic basis of lupus and other com­
plex genetic disorders is definitively addressed. Our concepts of 
pathogenesis and the therapeutic strategies attempted are certain to 
be profoundly influenced by knowing the genetic basis of these 
disorders. 
CD ... 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
20 r-------------------------.---�p�e�di�g r-e-es-- -. 
�Hispanic· 1 ped 
[X)Asian . 3 peds 
• Black· 5 peds 
15 - --- - - - - - - oWhite . 15 peds 
8 10 A _____ _ � - - c D E(ANA) 
en 
'tJ 
o 
..J 
5 
40 60 80 100% 40 60 80 100% 40 60 80 100% 40 60 80 100% 40 60 80 100% 
Homogenity (%) 
Recessive Dominant 
50% 100% 50% 49/92% 49/92% 
Penetrance (%) 
Figure 4. Simulation experiments with 2S pedigrees that are multi­
plex for lupus. Each panel presents the average lod scores obtained from a 
series of simulated models where the genetic homogeneity varies from 40% 
to 100%. Recessive models for linkage with lupus are presented in A where 
the penetrance is reduced to 50%; the 100% penetrance for a recessive model 
of lupus linkage is presented in B. The dominant models are less powerful. 
C presents a 50% penetrance model for dominant inheritance linked to the 
lupus phenotype. D explores the situation where female subjects have 92% 
penetrance and male subjects have 49% penetrance for a dominantly ex­
pressed gene linked to lupus. E evaluates the analogous model to D, except 
linkage with the presence of antinuclear antibodies is evaluated, instead of 
the lupus phenotype, which is presented inDo The contribution of pedigrees 
who identify themselves [ped(s)] as Hispanic, Oriental, white, or black are 
separately identified. Each model presented is the average from 4000 repli­
cates. 
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